Bioequivalence study of Pantoprazole 40mg
Not Applicable
Not yet recruiting
- Conditions
- Healthy volunteers.
- Registration Number
- IRCT20200623047902N7
- Lead Sponsor
- Sanamed pharma company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
General Health (liver, heart, and kidney)
Body Mass Index (18-28)
Informed consent
Age (18-55 years old)
Exclusion Criteria
Smoking
History of cardiovascular disease
History of liver and kidney disease
Alcoholism and Narcoticism
History of allergy to pantoprazole
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Pantoprazole in inhibiting H+/K+ ATPase in healthy volunteers?
How does Pantoprazole 40mg compare to other PPIs in terms of bioavailability and efficacy in fasting vs. fed states?
What biomarkers are associated with proton pump inhibitor response in gastrointestinal acid-related disorders?
What are the potential adverse events of Pantoprazole 40mg tablets and how are they managed in clinical practice?
How does Sanamed's Pantoprazole formulation compare to competitor drugs in terms of pharmacokinetic profiles and therapeutic outcomes?